Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric McDade

Showing results (91-100 of 194) with videos related to

Pageof 20
Sort By:
Brain : a Journal of Neurology|August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
The Lancet. Neurology|March 19, 2022
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational studyEstrella Morenas-Rodríguez, Yan Li, Brigitte Nuscher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2022
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brainsBrenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, et al.
Nature Communications|April 21, 2023
Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriersLogan Brase, Shih-Feng You, Ricardo D'Oliveira Albanus, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Pageof 20

Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Brain : a Journal of Neurology|August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
The Lancet. Neurology|March 19, 2022
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational studyEstrella Morenas-Rodríguez, Yan Li, Brigitte Nuscher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2022
Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brainsBrenna C Novotny, Maria Victoria Fernandez, Ciyang Wang, et al.
Nature Communications|April 21, 2023
Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriersLogan Brase, Shih-Feng You, Ricardo D'Oliveira Albanus, et al.
JAMA Network Open|December 12, 2019
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer DiseaseJorge J Llibre-Guerra, Yan Li, Suzanne E Schindler, et al.
Scientific Reports|April 29, 2017
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2018
Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's diseaseStephan Müller, Oliver Preische, Hamid R Sohrabi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2026
Plasma levels of an N-terminal tau fragment predict Alzheimer's and neurodegenerative disease biomarkers in autosomal dominant Alzheimer's diseaseStephanie A Schultz, Yiwen Rao, Lei Liu, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer diseaseJiaxin Cindy Tu, Peter R Millar, Jeremy F Strain, et al.
Pageof 20